THERAPY CELLS INC (OTCMKTS:TCEL) Shorted Shares Increased 22100% After Market Selling

The stock of THERAPY CELLS INC (OTCMKTS:TCEL) registered an increase of 22100% in short interest. TCEL’s total short interest was 22,200 shares in April as published by FINRA. Its up 22100% from 100 shares, reported previously.

The stock decreased 33.33% or $0.0001 during the last trading session, reaching $0.0002. About 7.96M shares traded. Therapy Cells, Inc. (OTCMKTS:TCEL) has 0.00% since April 17, 2018 and is . It has underperformed by 4.37% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Therapy Cells, Inc. develops and commercializes a technology for tendon repair for the human market. The company has market cap of $389,664. The Company’s technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. It currently has negative earnings. The firm was formerly known as Diamond Information Institute, Inc. and changed its name to Therapy Cells, Inc. in May 2011.